MicroRNA-124 regulates glucocorticoid sensitivity by targeting phosphodiesterase 4B in diffuse large B cell lymphoma

Gene

Volumn 558, Issue 1, 2015, Pages 173-180

  Kim, Jinyoung ^a   Jeong, Dawoom ^a   Nam, Jehyun ^a   Aung, Thazin Nwe ^a   Gim, Jeong An ^a   Park, Keon Uk ^b   Kim, Sang Woo ^a  

^a Pusan National University   (South Korea)

^b Keimyung University   (South Korea)

Author keywords

AKT mTOR MCL1; DLBCL; MicroRNA; PDE4B

Indexed keywords

CYCLIC AMP; DEXAMETHASONE; FORSKOLIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 124; PHOSPHODIESTERASE; PHOSPHODIESTERASE 4B; PROTEIN KINASE B; PROTEIN MCL 1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; GLUCOCORTICOID RECEPTOR; MICRORNA; MIRN124 MICRORNA, HUMAN; PHOSPHODIESTERASE IV;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; DRUG SENSITIVITY; EMBRYO; ENZYME INHIBITION; GENETIC REGULATION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STABLE EXPRESSION; UPREGULATION; DRUG RESISTANCE; GENETICS; METABOLISM; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DRUG RESISTANCE, NEOPLASM; GLUCOCORTICOIDS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICRORNAS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84923612314     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.01.001     Document Type: Article

References (43)

1. Abrams M.T., Robertson N.M., Yoon K., Wickstrom E. Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J. Biol. Chem. 2004, 279:55809-55817.
2. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
3. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
4. Conti M., Richter W., Mehats C., Livera G., Park J.Y., Jin C. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem. 2003, 278:5493-5496.
5. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998, 396:474-477.
6. Di Lisio L., Martinez N., Montes-Moreno S., Piris-Villaespesa M., Sanchez-Beato M., Piris M.A. The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. Blood 2012, 120:1782-1790.
7. Dremier S., Kopperud R., Doskeland S.O., Dumont J.E., Maenhaut C. Search for new cyclic AMP-binding proteins. FEBS Lett. 2003, 546:103-107.
8. Epstein P.M., Hachisu R. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 1984, 16:303-324.
9. Erlacher M., Michalak E.M., Kelly P.N., Labi V., Niederegger H., Coultas L., Adams J.M., Strasser A., Villunger A. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 2005, 106:4131-4138.
10. Eulalio A., Huntzinger E., Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008, 132:9-14.
11. Garofalo M., Croce C.M. MicroRNAs as therapeutic targets in chemoresistance. Drug Resist. Updat. 2013, 16:47-59.
12. Geley S., Hartmann B.L., Hala M., Strasser-Wozak E.M., Kapelari K., Kofler R. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression. Cancer Res. 1996, 56:5033-5038.
13. Hala M., Hartmann B.L., Bock G., Geley S., Kofler R. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines. Int. J. Cancer 1996, 68:663-668.
14. Hongo T., Yajima S., Sakurai M., Horikoshi Y., Hanada R. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood 1997, 89:2959-2965.
15. Kasinski A.L., Slack F.J. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 2011, 11:849-864.
16. Kaspers G.J., Veerman A.J., Pieters R., Van Zantwijk C.H., Smets L.A., Van Wering E.R., Van Der Does-Van Den Berg A. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 1997, 90:2723-2729.
17. Kaspers G.J., Pieters R., Van Zantwijk C.H., Van Wering E.R., Van Der Does-Van Den Berg A., Veerman A.J. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood 1998, 92:259-266.
18. Kilpinen H., Ylisaukko-Oja T., Hennah W., Palo O.M., Varilo T., Vanhala R., Nieminen-von Wendt T., von Wendt L., Paunio T., Peltonen L. Association of DISC1 with autism and Asperger syndrome. Mol. Psychiatry 2008, 13:187-196.
19. Kim S.W., Rai D., McKeller M.R., Aguiar R.C. Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL. Blood 2009, 113:6153-6160.
20. Kim S.W., Rai D., Aguiar R.C. Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma. Clin. Cancer Res. 2011, 17:6723-6732.
21. Kim S.W., Ramasamy K., Bouamar H., Lin A.P., Jiang D., Aguiar R.C. MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc. Natl. Acad. Sci. U. S. A. 2012, 109:7865-7870.
22. Ledderose C., Mohnle P., Limbeck E., Schutz S., Weis F., Rink J., Briegel J., Kreth S. Corticosteroid resistance in sepsis is influenced by microRNA-124-induced downregulation of glucocorticoid receptor-alpha. Crit. Care Med. 2012, 40:2745-2753.
23. Li C., Kim S.W., Rai D., Bolla A.R., Adhvaryu S., Kinney M.C., Robetorye R.S., Aguiar R.C. Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood 2009, 113:6681-6690.
24. Liang Y.J., Wang Q.Y., Zhou C.X., Yin Q.Q., He M., Yu X.T., Cao D.X., Chen G.Q., He J.R., Zhao Q. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013, 34:713-722.
25. Lu Y., Yue X., Cui Y., Zhang J., Wang K. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. Biochem. Biophys. Res. Commun. 2013, 441:873-879.
26. Lv M., Zhang X., Jia H., Li D., Zhang B., Zhang H., Hong M., Jiang T., Jiang Q., Lu J., Huang X., Huang B. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways. Leukemia 2012, 26:769-777.
27. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J.C., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H., Muir W.J., Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310:1187-1191.
28. Ning B.F., Ding J., Liu J., Yin C., Xu W.P., Cong W.M., Zhang Q., Chen F., Han T., Deng X., Wang P.Q., Jiang C.F., Zhang J.P., Zhang X., Wang H.Y., Xie W.F. Hepatocyte nuclear factor 4alpha-nuclear factor-kappaB feedback circuit modulates liver cancer progression. Hepatology 2014, 60(5):1607-1619.
29. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., Cidlowski J.A. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J. Biol. Chem. 1999, 274:27857-27866.
30. Pujols L., Mullol J., Roca-Ferrer J., Torrego A., Xaubet A., Cidlowski J.A., Picado C. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am. J. Physiol. Cell Physiol. 2002, 283:C1324-C1331.
31. Rainer J., Ploner C., Jesacher S., Ploner A., Eduardoff M., Mansha M., Wasim M., Panzer-Grumayer R., Trajanoski Z., Niederegger H., Kofler R. Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia 2009, 23:746-752.
32. Schlossmacher G., Stevens A., White A. Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells. J. Endocrinol. 2011, 211:17-25.
33. Schmidt S., Rainer J., Ploner C., Presul E., Riml S., Kofler R. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ. 2004, 11(Suppl. 1):S45-S55.
34. Shipp M.A., Ross K.N., Tamayo P., Weng A.P., Kutok J.L., Aguiar R.C., Gaasenbeek M., Angelo M., Reich M., Pinkus G.S., Ray T.S., Koval M.A., Last K.W., Norton A., Lister T.A., Mesirov J., Neuberg D.S., Lander E.S., Aster J.C., Golub T.R. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 2002, 8:68-74.
35. Skalhegg B.S., Tasken K. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front. Biosci. 2000, 5:D678-D693.
36. Smith P.G., Wang F., Wilkinson K.N., Savage K.J., Klein U., Neuberg D.S., Bollag G., Shipp M.A., Aguiar R.C. The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. Blood 2005, 105:308-316.
37. Soderling S.H., Beavo J.A. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr. Opin. Cell Biol. 2000, 12:174-179.
38. Tissing W.J., Meijerink J.P., den Boer M.L., Pieters R. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003, 17:17-25.
39. Visvanathan J., Lee S., Lee B., Lee J.W., Lee S.K. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 2007, 21:744-749.
40. Wei G., Twomey D., Lamb J., Schlis K., Agarwal J., Stam R.W., Opferman J.T., Sallan S.E., den Boer M.L., Pieters R., Golub T.R., Armstrong S.A. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 2006, 10:331-342.
41. Wong K.Y., So C.C., Loong F., Chung L.P., Lam W.W., Liang R., Li G.K., Jin D.Y., Chim C.S. Epigenetic inactivation of the miR-124-1 in haematological malignancies. PLoS One 2011, 6:e19027.
42. Xie L., Zhang Z., Tan Z., He R., Zeng X., Xie Y., Li S., Tang G., Tang H., He X. microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. Mol. Cell. Biochem. 2014, 392(1-2):153-159.
43. Xing W., Hao L., Yang X., Li F., Huo H. Glucocorticoids induce apoptosis by inhibiting microRNA cluster miR1792 expression in chondrocytic cells. Mol. Med. Rep. 2014, 10:881-886.